Merck (NYSE: MRK) is scheduled to report its This fall 2020 outcomes on Thursday, February 4. We count on the corporate to doubtless publish income barely beneath and earnings in-line with the consensus estimates, partly attributable to decrease anticipated gross sales of vaccines, corresponding to Gardasil and Proquad. Tha
www.nasdaq.com
Merck This fall Earnings Preview: Keytruda And Gardasil In Focus
